[ET Net News Agency, 14 July 2021] ALPHAMAB-B (09966) rose 6.15% to HK$27.6.
It hits an intra-day high of HK$27.65, hitting a historical high, and an intra-day low
of HK$25.8. The total shares traded was 1.67 million, with a value of HK$45.1m. The active
buy/sell ratio is 85:15, with net buying turnover of HK$30.79m. CHINA INT'L CAPITAL CORP
HK accounts for greatest net responsive buying turnover of HK$2.45m, with volume weighted
average price of HK$26.7. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$9.67m, with volume weighted average price of HK$27.245. The stock
has risen a combined 17.45% over the past 4 consecutive trading days.
The Hang Seng Index now fell 204 points, or 0.73% to 27,758; the Hang Seng China
Enterprises Index now fell 71 points, or 0.7% to 10,042; the Hang Seng TECH Index now fell
10 points, or 0.14% to 7,648; with an overall turnover of HK$39.05b.
The SSE Composite Index now fell 26 points, or 0.75% to 3,539, with an overall turnover
of RMB181.32b.
The SZSE Component Index now fell 81 points, or 0.54% to 15,107, with an overall
turnover of RMB131.16b.
Basic Information
-------------------------------------------
Nominal 27.600 % Chg +6.15%
High 27.650 Low 25.800
Shares Tr 1.67m Turnover 45.1m
10-D SMA 25.155 %H.V 57.592
20-D SMA 24.178 VWAP 27.066
50-D SMA 20.993 RSI14 69.681
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 85:15, with net buying
turnover of HK$30.79m, rising a combined 17.45% over the past 4 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
ALPHAMAB-B (09966) 27.60 +6.15
JACOBIO-B (01167) 21.95 -4.77
GENSCRIPT BIO (01548) 39.55 +5.47
INNOVENT BIO (01801) 88.00 +1.73
JXR (01951) 16.88 +4.84
JW THERAP-B (02126) 22.45 +4.91
BRII-B (02137) 21.90 -4.58
WUXI BIO (02269) 141.40 +7.69
TIGERMED (03347) 180.00 +1.75
CANSINOBIO-B (06185) 329.00 +3.72
-------------------------------------------------
(ed)